Auctus Biologics

Auctus Biologics was founded in 2018 and is headquartered in New York, USA. It is a portfolio company of Ichor Therapeutics. The company uses RPtag-based antibody-like scaffolds to develop new therapies and is currently working on next-generation biologics, exploring targets in extreme anatomical environments such as the gut, where antibodies cannot be used.